U.S. federal trademark · Serial No. 75186042
gene-based pharmaceutical preparations used to elicit an immune response to selected antigens for the treatment or prevention of infections disease or cancer
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.